BioNexus Gene Lab Stock (NASDAQ:BGLC)


Chart

Previous Close

$0.29

52W Range

$0.28 - $3.39

50D Avg

$0.39

200D Avg

$0.53

Market Cap

$5.13M

Avg Vol (3M)

$383.00K

Beta

1.87

Div Yield

-

BGLC Company Profile


BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

MY

Employees

30

IPO Date

Jan 08, 2021

Website

BGLC Performance


Peer Comparison


TickerCompany
SNESSenesTech, Inc.
OECOrion Engineered Carbons S.A.
FULH.B. Fuller Company
BCPCBalchem Corporation
IOSPInnospec Inc.
NEUNewMarket Corporation
GEVOGevo, Inc.
LOOPLoop Industries, Inc.